$NXTS
Nexentis Technologies Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$0.570
▲After hours+0.18%+$0.001After hours
Nexentis Technologies Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is NXTS up today? It is at $0.570 (+7.26%), and our scanner flagged it 31 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment NXTS spikes, and full due diligence on NXTS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $NXTS 31 times in the last 30 days. Create a free account to track $NXTS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on NXTS from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystExecutive / Board Change · Unregistered Share Sale, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Oct 22, 2026 · 12 days agoAcross every filing on file, supply equal to 12521.5% of the tradeable float is in play - 102.9% has already been sold, and 12418.7% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
Recent share offering + active shelf on file — the company raised capital and can raise more
1,453,333 new shares · Priced at $7.056/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Sidi Liat Director | Acquired (grant/award) | +15K 1.0% of company | added 100% | 15K | n/a | Oct 15, 26 |
Arbib Eliahou Director | Acquired (grant/award) | +19K 1.3% of company | added 100% | 20K | n/a | Oct 15, 26 |
Berenstein Israel Yakov Director | Acquired (grant/award) | +19K 1.3% of company | added 100% | 20K | n/a | Oct 15, 26 |
Zakai Shlomo Officer | Acquired (grant/award) | +51K 3.5% of company | added 100% | 60K | n/a | Oct 15, 26 |
Palach David Officer | Acquired (grant/award) | +102K 7.0% of company | added 100% | 120K | n/a | Oct 15, 26 |
Weiss Amitay Director | Acquired (grant/award) | +102K 7.0% of company | added 100% | 120K | n/a | Oct 15, 26 |
Rosenbloom Ronen Director | Acquired (grant/award) | +19K 1.3% of company | added 100% | 20K | n/a | Oct 15, 26 |
Barda Lital Officer | Acquired (grant/award) | +51K 3.5% of company | added 100% | 60K | n/a | Oct 15, 26 |
Itzhaik Asaf Director | Acquired (grant/award) | +15K 1.0% of company | added 100% | 15K | n/a | Oct 15, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on NXTS from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
NXTS last traded at $0.570, up 7.26% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Nexentis Technologies Inc. Common Stock (NXTS) is next expected to report earnings on Thursday, November 12, 2026, about 9 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The NXTS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged NXTS 31 times in the last 30 days.
NXTS (Nexentis Technologies Inc. Common Stock) trades on XNAS, with a market cap of about $850,636 in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge NXTS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$NXTS discussion
Sign in to ask a question or join the discussion.